Heart Failure and Cardiac Care at Home in North Shropshire
Have this page read to you
Why the Type Matters for Home Care
The type of heart failure does not change the fundamental daily care requirements — fluid monitoring, medication management, symptom observation, falls prevention, nutritional support. But it does affect the medication regimen, the specific monitoring priorities, and the underlying conditions that need to be managed alongside the heart failure itself. We build this specificity into every heart failure care plan from the assessment.
The Symptoms That Shape Daily Care
Breathlessness
Breathlessness — dyspnoea — is the cardinal symptom of heart failure. It occurs because fluid accumulates in the lungs when the failing heart cannot pump blood forward efficiently (pulmonary oedema). In mild heart failure, breathlessness occurs only with exertion. As heart failure progresses, breathlessness occurs at lower and lower levels of activity — and in advanced heart failure, at rest.
Orthopnoea — breathlessness when lying flat, because fluid redistributes from the legs to the lungs in the supine position — is a specific symptom of heart failure that affects sleep and the position in which a person must rest. Many people with heart failure sleep propped up on multiple pillows for this reason.
Paroxysmal nocturnal dyspnoea — sudden severe breathlessness waking the person from sleep — is both distressing and a sign of significant fluid overload.
What we do: We observe and document the person's breathlessness level at every visit — not vaguely, but specifically. Which activities produce breathlessness? Has the person needed to add a pillow in the last week? Have they been woken at night? A documented worsening in breathlessness pattern is one of the most important early warning signs of decompensation — and early escalation to the heart failure nurse or GP can initiate diuretic adjustment that prevents a hospital admission.
Fluid Retention and Weight Monitoring
The accumulation of fluid is the most clinically critical feature of heart failure decompensation. Fluid retention produces oedema — typically in the ankles, feet, and lower legs, and in severe cases extending to the abdomen (ascites) and lungs (pulmonary oedema). The rate of fluid accumulation — and therefore the rate of decompensation — can be assessed at home through daily weight monitoring.
Daily weighing is one of the most important self-management tasks in heart failure. A weight gain of more than 2 kilograms in 48 hours, or more than 3 kilograms in a week, typically indicates significant fluid retention that requires a medication adjustment — usually an increase in diuretic dose. This is the "flexible diuretic" strategy that heart failure nurses teach and that requires the person (or their carer) to respond promptly.
What we do: Daily weight monitoring is built into the care plan for every heart failure client where this is the prescribed self-management approach. We weigh the person at the same time each morning (before breakfast, after using the toilet, with the same clothes), record the weight, compare it to the previous day's weight, and communicate any significant increase to the heart failure nurse or GP immediately. We do not wait for a scheduled appointment to report a 2-kilogram weight gain.
We also observe and document ankle and leg oedema at every visit — its severity, whether it has changed since the previous day, and whether it is extending above the ankle. This is a simple but clinically useful daily assessment that the clinical team cannot make between appointments.
Fatigue
The profound fatigue of heart failure reflects inadequate cardiac output to meet the metabolic demands of physical activity. The muscles — including the muscles of respiration — are not receiving adequate blood flow and oxygen, and the resulting fatigue is physiological rather than psychological.
Heart failure fatigue is characteristically disproportionate to the effort that produces it. A person with advanced heart failure may be exhausted by walking from the bedroom to the bathroom. The gap between what they could do six months ago and what they can do today is not deconditioning — it is the measurable consequence of a heart that is working harder and achieving less.
What we do: We structure all care tasks around fatigue management. We pace activities to prevent the exertional breathlessness and fatigue that rapidly consumes a person's limited daily energy. We protect the higher-energy periods of the day for the activities that matter most to the person. We build rest periods into every visit. And we observe and document changes in fatigue level, because a significant increase in fatigue — without another obvious cause — is a clinical signal that warrants prompt review.
Peripheral Oedema — The Practical Consequences
Oedematous ankles and legs affect more than appearance. Tight, swollen skin is fragile and at high risk of breakdown. Oedema makes footwear difficult or impossible, affecting mobility and falls risk. Severe leg oedema can produce weeping of fluid through the skin (lymphorrhoea), creating a wound care need. And the discomfort of severe leg oedema — the tightness, the heaviness, the restricted movement — affects sleep, mood, and quality of life significantly.
What we do: We provide daily skin care for oedematous legs — moisturising skin that is at risk of breakdown, monitoring for early signs of breakdown or infection (cellulitis in oedematous legs is a common and serious complication), and ensuring correct elevation when the person is resting. We support the correct application of compression hosiery where this is prescribed, and we communicate skin integrity concerns to the district nursing team promptly.
Cardiac Cachexia
In advanced heart failure, a process called cardiac cachexia — progressive loss of body weight, fat, and muscle — can develop. It reflects the metabolic abnormalities of chronic severe heart failure and is a marker of poor prognosis. Maintaining nutritional intake in someone with cardiac cachexia is both clinically important and practically challenging — appetite is poor, breathlessness makes eating effortful, and early satiety (feeling full very quickly) limits meal sizes.
What we do: We monitor weight and nutritional intake as a clinical priority in our heart failure clients. We prepare frequent small meals rather than three large ones, adapted to what the person can tolerate. We communicate nutritional decline to the GP and heart failure team, because nutritional support — sometimes including dietitian involvement — is an active component of advanced heart failure management.
Medication Management — The Cornerstone of Heart Failure Treatment
Heart failure medication management is among the most complex in home care. The regimen is extensive, the interactions are numerous, the side effects are clinically significant, and the consequences of non-adherence are measurable in rehospitalisation rates and mortality.
The "Four Pillars" of HFrEF Treatment
For people with HFrEF, the evidence-based medication framework includes four classes of drug that together significantly reduce mortality and hospitalisation:
ACE inhibitors or ARBs (ramipril, lisinopril, candesartan) or sacubitril/valsartan (Entresto) — reduce the neurohormonal activation that drives heart failure progression. Sacubitril/valsartan (ARNI) has been shown to be superior to enalapril in reducing mortality and hospitalisation and is now preferred in guidelines for eligible patients.
Beta-blockers (bisoprolol, carvedilol, metoprolol) — reduce heart rate, reduce sympathetic activation, and improve cardiac function over time. Critically, beta-blockers must be started at low doses and titrated slowly — they can initially worsen heart failure if started too quickly.
Mineralocorticoid receptor antagonists (spironolactone, eplerenone) — reduce fluid retention and improve survival. They require monitoring for hyperkalaemia (elevated potassium), which can be serious.
SGLT2 inhibitors (empagliflozin, dapagliflozin) — originally developed for diabetes, now proven to reduce hospitalisation and mortality in both HFrEF and HFpEF. They also have renal protective effects and promote mild diuresis.
Diuretics — The Most Visible Medication
Loop diuretics — furosemide, bumetanide — are the primary tool for managing fluid overload in heart failure. They are not disease-modifying (they don't improve survival) but they are essential for symptom control. Diuretic dose often needs to be adjusted — increased when fluid is accumulating, reduced when the person is dehydrated.
The "flexible diuretic" approach — where the dose is adjusted by the person or carer based on daily weight monitoring — is one of the most effective tools in heart failure self-management. It requires both understanding of the principle and the confidence to act on it. We support this approach fully — explaining it clearly to clients and families, monitoring the weight measurements that trigger dose changes, and communicating with the heart failure nurse when an adjustment is needed.
Diuretics produce their effect through increased urine output, which means toilet access and urgency management are practical care considerations. We factor this into personal care timing and daily routine.
Other Cardiac Medications
Many people with heart failure take anticoagulants (warfarin, apixaban) for atrial fibrillation, which is common in heart failure. Anticoagulants require specific management considerations — falls risk, drug interactions, the importance of never missing a dose without clinical guidance.
Nitrates for angina, statins for cholesterol management, ivabradine for heart rate control, digoxin for rate control in atrial fibrillation — the heart failure medication list for an older person can be extensive. We manage every medication through our eMAR system with real-time documentation, and we are specifically alert to the side effect profiles that are clinically relevant in heart failure.
Medication and the Kidney
The kidneys are deeply involved in heart failure. Reduced cardiac output means reduced renal perfusion. Many heart failure medications have direct renal effects. Regular monitoring of kidney function is a standard component of heart failure management, and changes in kidney function directly affect medication dosing.
We are trained to recognise the symptoms that may indicate acute kidney injury in people with heart failure — reduced urine output, increased fatigue, confusion, and to communicate these promptly to the clinical team. We do not adjust medication doses based on our observations, but we ensure that the observations reach the people who can.
Recognising Decompensation — The Most Important Clinical Skill in Heart Failure Home Care
Acute decompensated heart failure — the sudden worsening of heart failure symptoms requiring urgent clinical intervention, usually hospitalisation — is the most common reason for emergency admission in heart failure patients. Each hospitalisation for decompensated heart failure is associated with a measurable worsening of prognosis and a step down in functional capacity.
Many decompensations are preventable. The early warning signs of decompensation — weight gain, worsening breathlessness, increased oedema, reduced exercise tolerance — typically precede the acute deterioration by days. A carer who recognises these signs and escalates promptly can initiate the diuretic adjustment that prevents a hospital admission.
The early warning signs we monitor for:
Weight gain of 2kg or more in 48 hours, or 3kg or more in a week
Worsening breathlessness — on lower levels of activity than usual, at rest, or at night
Needing to add a pillow to sleep
Increasing ankle and leg swelling
New or worsening cough (fluid in the lungs can produce a productive cough)
Increasing fatigue — activity levels falling below recent baseline
Reduced urine output despite usual diuretic dose
Confusion (which in an older adult with heart failure may reflect low cardiac output rather than a neurological cause)
Palpitations — the onset of atrial fibrillation or other arrhythmia can precipitate acute decompensation
What we do: We document these observations specifically at every visit. Not "client seemed well" but whether the weight is up, whether the ankles are more swollen, whether breathlessness has changed. We communicate changes promptly — directly to the heart failure nurse or GP where there is an established escalation pathway, or via the family where this is the agreed arrangement. We do not wait for a scheduled review to report observations that indicate clinical deterioration.
Heart failure is one of the most common, most serious, and most frequently misunderstood conditions in older adults. It is not, despite the name, a condition in which the heart stops. It is a condition in which the heart cannot pump blood as efficiently as the body requires — producing a cascade of consequences that affect breathing, fluid balance, energy levels, kidney function, and the capacity for everyday physical activity.
Approximately 920,000 people in the UK are living with heart failure, with around 200,000 new cases diagnosed every year. Diagnosed cases are predicted to nearly double by 2040, driven by an ageing population and improved survival rates after heart attacks that leave more people living with cardiac damage. Around 670,000 people in England alone have a GP diagnosis of heart failure.
The statistics that matter most for understanding why home care is important in heart failure are the survival figures. One-year survival after a heart failure diagnosis is 75.9% — and 10-year survival is 24.5%. Heart failure accounts for one million NHS bed days per year and is one of the most common causes of emergency hospital admission in England.
These are significant numbers. They describe a condition that is serious, progressive, and demanding — in terms of daily self-management, medication complexity, and the early symptom recognition that prevents the unplanned hospital admissions that define so much of heart failure's clinical course.
Home care in heart failure is not a supplement to clinical management. It is part of it. The daily monitoring, the medication adherence, the fluid management, the early escalation of deteriorating symptoms — these are the things that keep people out of hospital, that extend the period of stable function, and that make it possible for someone with heart failure to live well at home rather than spending their remaining years in and out of acute wards.
At North Shropshire Homecare we provide specialist cardiac and heart failure home care across Whitchurch, Wem, Prees, Whixall, and the surrounding villages of North Shropshire.
Understanding Heart Failure — The Types That Shape the Care
Heart failure is not a single condition. Understanding which type a person has matters for both the clinical management and the daily care approach.
-
HFrEF — sometimes called systolic heart failure — occurs when the heart muscle has been damaged and can no longer contract strongly enough to pump adequate blood out with each beat. The ejection fraction (the percentage of blood pumped out of the left ventricle with each contraction) is reduced, typically below 40%. 65.1% of people with HFrEF are male, reflecting the predominance of ischaemic heart disease (coronary artery disease, heart attacks) as the underlying cause.
HFrEF has the strongest evidence base for pharmacological treatment — the neurohormonal blockade with ACE inhibitors or ARNIs (sacubitril/valsartan), beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors (empagliflozin, dapagliflozin) — the so-called "four pillars" — has transformed outcomes for people with HFrEF when they are all prescribed and taken correctly.
-
HFpEF — sometimes called diastolic heart failure — occurs when the heart muscle is stiff and does not relax normally between contractions, reducing the amount of blood that fills the heart with each beat. The ejection fraction is preserved (typically above 50%), but the heart still cannot meet the body's demands. HFpEF has a more even sex distribution than HFrEF (48.2% male, 51.8% female). It is more strongly associated with hypertension, obesity, diabetes, and atrial fibrillation.
HFpEF has historically been harder to treat than HFrEF, though SGLT2 inhibitors have recently shown meaningful benefit in this population as well. The management focus in HFpEF is on controlling the underlying conditions, managing fluid balance, and optimising quality of life.
-
A third category — ejection fraction between 40% and 50% — is increasingly recognised and treated with elements of both HFrEF and HFpEF approaches.
Falls Prevention in Heart Failure
Falls risk is significantly elevated in heart failure, from multiple compounding causes:
Orthostatic hypotension — the drop in blood pressure on standing from sitting or lying — is common in heart failure and exacerbated by diuretics (which reduce fluid volume) and by vasodilating medications (ACE inhibitors, nitrates). The dizziness that follows rapid standing can cause a fall before the person has fully uprighted.
Peripheral muscle weakness — inadequate cardiac output and the neurohormonal changes of heart failure reduce skeletal muscle perfusion and mass. The resulting weakness, particularly in the legs, increases falls risk during transitions and walking.
Medication side effects — beta-blockers can cause dizziness and fatigue. Antiarrhythmics can affect balance. Anticoagulants (required by many heart failure patients for atrial fibrillation) mean that a fall that would cause a bruise in someone without anticoagulation can cause a serious bleeding event.
What we do: Falls prevention for heart failure clients begins with the specific risks of this condition. We encourage slow position changes — sitting at the edge of the bed for 30 seconds before standing, holding a stable surface when standing until balance is confirmed. We assess and address environmental hazards. We are aware of the anticoagulation status of our heart failure clients and communicate any fall — however apparently minor — to the family and clinical team, because a fall on anticoagulation requires clinical assessment.
What We Provide — The Practical Care
Personal Care
Personal care for someone with heart failure requires attention to breathlessness, fatigue, oedema, and the specific medication effects that affect how the person presents at each visit.
Morning personal care — which typically coincides with the diuretic taking effect — needs to account for increased urinary urgency, and we time bathroom access accordingly. Bathing or showering requires awareness of the breathlessness that hot water and steam can provoke, and the positioning that minimises exertion. Dressing oedematous legs in compression hosiery, where prescribed, requires specific technique and patience.
We complete daily weight measurement as part of the morning routine before any food or drink — a specific clinical task that is as important as any medication administration.
Nutrition and Fluid Management
Dietary management in heart failure involves navigating several specific considerations:
Sodium restriction — reducing dietary sodium reduces fluid retention. Many people with heart failure are advised to limit sodium intake, which affects meal preparation choices significantly.
Fluid restriction — in advanced heart failure, total fluid intake may be restricted (typically to 1.5–2 litres per day). This is one of the more difficult aspects of heart failure self-management and requires careful daily monitoring of all fluid consumed.
Potassium monitoring — MRAs and SGLT2 inhibitors affect potassium levels. High-potassium foods (bananas, potatoes, oranges) may need to be moderated. We are aware of the dietary potassium implications for clients on these medications.
Small, frequent meals — large meals increase cardiac workload through the post-prandial increase in blood flow to the gastrointestinal tract. Smaller, more frequent meals reduce this demand.
Medication Management
Full eMAR documentation of every dose, with real-time recording of timing and any refusal or side effect. Specific attention to the weight-triggered diuretic adjustments that form part of many heart failure management plans. Communication of medication concerns to the GP and heart failure nurse.
Cardiac Devices — Pacemakers, ICDs, and CRT
Many people with heart failure have implanted cardiac devices — pacemakers, implantable cardioverter-defibrillators (ICDs), or cardiac resynchronisation therapy (CRT) devices. These devices require specific awareness from carers:
ICDs — deliver a shock to restore normal rhythm if a life-threatening arrhythmia is detected. A shock from an ICD is alarming for both the person and anyone nearby. Our carers are trained to understand what an ICD shock is, that it does not require emergency services unless the person is symptomatic afterwards, and the escalation protocol for multiple shocks or continued symptoms.
CRT devices — improve the coordination of the heart's contractions in people with certain types of heart failure. They require no daily management but specific awareness of their presence when planning activities or positioning.
We document the presence of any cardiac device in the care plan and ensure that every carer visiting the client has read and understood the relevant protocol.
Working With the Heart Failure Clinical Team
Heart failure management is multidisciplinary. The GP, the cardiologist, the heart failure specialist nurse, the community pharmacist, the district nurse, the dietitian — each plays a role in managing a condition that touches multiple organ systems and requires constant titration of a complex medication regimen.
Heart failure specialist nurses are one of the most important resources in community heart failure management — they provide the expert telephone support, medication adjustments, and community follow-up that significantly reduces hospitalisation rates. NHS England's virtual ward programme for heart failure — which monitors patients at home following discharge through remote technology and specialist nurse support — is an expanding component of heart failure management that we work alongside where it is in place.
We are the consistent daily presence that connects all these clinical inputs to the daily reality of the person's life. We implement monitoring plans, we communicate observations, we escalate deterioration, and we ensure that the clinical team is never making decisions in the absence of accurate daily information.
The End-of-Life Dimension
Heart failure has a prognostic trajectory that is less predictable than most cancers but more serious than many people realise. The 10-year survival of 24.5% puts it in a similar bracket to many cancer diagnoses. Advanced heart failure — where symptoms are present at rest, where multiple hospitalisations have occurred, where optimal medical therapy is no longer producing improvement — is a terminal illness, and the people living with it deserve the same quality of palliative care as those with a cancer diagnosis.
We work alongside Severn Hospice's palliative care team, the GP, and the heart failure nurse in providing end-of-life heart failure care at home. Symptom management — breathlessness, oedema, fatigue, anxiety — through both pharmacological and non-pharmacological approaches. Comfort and dignity through the final phase. Support for the family through what is often a long and emotionally demanding journey.
Arrange a Free Home Assessment
If you or a family member is living with heart failure in North Shropshire and would benefit from specialist home care support — whether for daily monitoring, medication management, or more intensive care during a period of instability — we would be glad to talk.
A free home assessment costs nothing and commits you to nothing.
📞 01948 411222 — 24 hours, 365 days
✉️ mail@nshomecare.co.uk
North Shropshire Homecare
The Coach House, 15/17 Green End, Whitchurch, SY13 1AD
Providing specialist heart failure and cardiac care at home across Whitchurch, Wem, Prees, Whixall, Higher Heath, Tilstock, Ash, and the surrounding villages of North Shropshire. CQC Rated Good. Independently Owned. Locally Staffed.
-
The information on this page has been checked for clinical accuracy and aligns with current best practices for Heart Failure and Cardiac Care.
REVIEWED BY: Alice Allen CQC Registered Manager
Next review July 2027.